# Venlafaxine

## Effexor XR 75mg

| TAH Drug Code      | [OEFE7](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OEFE7)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Major depressive disorder; generalized anxiety disorder; social anxiety disorder; panic disorder.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Dosing             | Should be taken with food (XR cap: Swallow whole, do not chew/crush.). Dosage: 75 mg once daily. After 2 weeks, the dose may be increased to 150 mg once daily & further to 225 mg once daily if needed.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Concomitant use of MAOIs, including linezolid or IV methylene blue, within 14 days of discontinuing an MAOI, or within 7 days of venlafaxine hydrochloride discontinuation or use. Hypersensitivity to venlafaxine hydrochloride, desvenlafaxine, or to any excipients in the formulation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | Dizziness, sedation, dry mouth, insomnia, nervousness, tremor, somnolence, anorexia, constipation, nausea, vomiting, abnormal ejaculation/orgasm (males), erectile dysfunction, urinary hesitancy, sweating, asthenia, hypertension, hot flushes, ecchymosis, mucous membrane bleeding, thrombocytopenia, hypercholesterolaemia, yawning, fatigue, nausea, appetite & weight loss, decreased libido, sweating, anorexia, visual disturbances. Cardiovascular: Hypertension (3% to 13%) Dermatologic: Sweating symptom (6.7% to 25% ) Endocrine metabolic: Weight loss (3% to 47% ) Gastrointestinal: Constipation (8% to 15% ), Loss of appetite (8% to 22% ), Nausea (21% to 58% ), Xerostomia (12% to 22% ) Neurologic: Asthenia (8% to 19% ), Dizziness (11% to 23.9% ), Dream disorder (3% to 7% ), Headache (25% to 38% ), Insomnia (14% to 24% ), Somnolence (14% to 26% ), Tremor (1.1% to 10.2% ) Ophthalmic: Blurred vision (4% to 6% ) Psychiatric: Feeling nervous (4% to 21.3% ) Reproductive: Abnormal ejaculation (2.2% to 19% ), Impotence (2.1% to 6% ), Orgasm disorder (2% to 5% ) |
| Pregnancy          | Human Data Suggest Risk in 3rd Trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| More Info          | [UpToDate](https://www.uptodate.com/contents/venlafaxine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

## Faxine 37.5mg

| TAH Drug Code      | [OFAX](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OFAX)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of depression, including melancholia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Dosing             | Adult Initially 75 mg/day in 2-3 divided doses, can be increased in increments of up to 75 mg/day at intervals of ＞﹦ 4 days. Dose can be titrated up to 225 mg/day in moderate depression & 375 mg/day for severe depression                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | Concomitant use of MAOIs, including linezolid or IV methylene blue, within 14 days of discontinuing an MAOI, or within 7 days of venlafaxine hydrochloride discontinuation or use. Hypersensitivity to venlafaxine hydrochloride, desvenlafaxine, or to any excipients in the formulation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Adverse Effects    | Dizziness, sedation, dry mouth, insomnia, nervousness, tremor, somnolence, anorexia, constipation, nausea, vomiting, abnormal ejaculation/orgasm (males), erectile dysfunction, urinary hesitancy, sweating, asthenia, hypertension, hot flushes, ecchymosis, mucus membrane bleeding, thrombocytopenia, hypercholesterolemia, yawning, fatigue, nausea, appetite & wt loss, decreased libido, sweating, anorexia, visual disturbances Cardiovascular: Hypertension (3% to 13%) Dermatologic: Sweating symptom (6.7% to 25% ) Endocrine metabolic: Weight loss (3% to 47% ) Gastrointestinal: Constipation (8% to 15% ), Loss of appetite (8% to 22% ), Nausea (21% to 58% ), Xerostomia (12% to 22% ) Neurologic: Asthenia (8% to 19% ), Dizziness (11% to 23.9% ), Dream disorder (3% to 7% ), Headache (25% to 38% ), Insomnia (14% to 24% ), Somnolence (14% to 26% ), Tremor (1.1% to 10.2% ) Ophthalmic: Blurred vision (4% to 6% ) Psychiatric: Feeling nervous (4% to 21.3% ) Reproductive: Abnormal ejaculation (2.2% to 19% ), Impotence (2.1% to 6% ), Orgasm disorder (2% to 5% ) |
| Pregnancy          | Human Data Suggest Risk in 3rd Trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| More Info          | [UpToDate](https://www.uptodate.com/contents/venlafaxine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

